Spotlight on Peginterferon- -2a (40KD) in Chronic Hepatitis C

Author： Perry C.M.   Jarvis B.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.16, Iss.3, 2002-01, pp. : 213-217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on Peginterferon-α-2a (40 kD) Plus Ribavirin in the Management of Chronic Hepatitis C Mono-Infection†

By Keam Susan J.   Cvetković Risto S.  

BioDrugs, Vol. 23, Iss. 1, 2009-01 ,pp. : 63-68

Adis International

Access to resources Recommend Favorite

Peginterferon- -2a (40kD) and Ribavirin in Patients with Chronic Hepatitis C: A Phase II Open-Label Study

By Sulkowski M.  

BioDrugs, Vol. 16, Iss. 2, 2002-02 ,pp. : 105-109

Adis International

Access to resources Recommend Favorite

Interferon- -2a: A Review of its Use in Chronic Hepatitis C

By Perry C.M.   Wilde M.I.  

BioDrugs, Vol. 10, Iss. 1, 1998-07 ,pp. : 65-89

Adis International

Access to resources Recommend Favorite

Development of Pegylated Interferons for the Treatment of Chronic Hepatitis C

By Kozlowski A.   Charles S.A.   Harris J.M.  

BioDrugs, Vol. 15, Iss. 7, 2001-07 ,pp. : 419-429

Adis International

Access to resources Recommend Favorite

Interleukin-2 Plus Ribavirin Versus Interferon- -2b Plus Ribavirin in Patients with Chronic Hepatitis C Who Did Not Respond to Previous Interferon- -2b Treatment

By Mariano Malaguarnera  

BioDrugs, Vol. 18, Iss. 6, 2004-01 ,pp. : 407-413

Adis International

Access to resources Recommend Favorite